These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
392 related articles for article (PubMed ID: 11921197)
1. Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention. Zujewski J Environ Mol Mutagen; 2002; 39(2-3):264-70. PubMed ID: 11921197 [TBL] [Abstract][Full Text] [Related]
2. From adjuvant therapy to breast cancer prevention: BCPT and STAR. Dunn BK; Ford LG Breast J; 2001; 7(3):144-57. PubMed ID: 11469927 [TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of breast cancer in the older patient. Minton SE Hematol Oncol Clin North Am; 2000 Feb; 14(1):113-30. PubMed ID: 10680075 [TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women. Decensi A; Robertson C; Guerrieri-Gonzaga A; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Galimberti V; Cassano E; Moroni SM; Formelli F; Lien EA; Pelosi G; Johnson KA; Bonanni B J Clin Oncol; 2009 Aug; 27(23):3749-56. PubMed ID: 19597031 [TBL] [Abstract][Full Text] [Related]
5. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. Jordan VC; Gapstur S; Morrow M J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060 [TBL] [Abstract][Full Text] [Related]
6. The selective estrogen receptor modulators in breast cancer prevention. Li F; Dou J; Wei L; Li S; Liu J Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504 [TBL] [Abstract][Full Text] [Related]
7. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials. Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916 [TBL] [Abstract][Full Text] [Related]
8. Selective estrogen receptor modulators and aromatase inhibitors for breast cancer chemoprevention. Vogel VG Curr Drug Targets; 2011 Dec; 12(13):1874-87. PubMed ID: 21158712 [TBL] [Abstract][Full Text] [Related]
9. The MORE trial: multiple outcomes for raloxifene evaluation--breast cancer as a secondary end point: implications for prevention. Dickler MN; Norton L Ann N Y Acad Sci; 2001 Dec; 949():134-42. PubMed ID: 11795345 [TBL] [Abstract][Full Text] [Related]
10. Breast cancer prevention with selective estrogen receptor modulators: a perspective. Pritchard KI Ann N Y Acad Sci; 2001 Dec; 949():89-98. PubMed ID: 11795385 [TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of breast cancer with fenretinide. Torrisi R; Decensi A; Formelli F; Camerini T; De Palo G Drugs; 2001; 61(7):909-18. PubMed ID: 11434448 [TBL] [Abstract][Full Text] [Related]
12. Carcinoma in situ outcomes in National Surgical Adjuvant Breast and Bowel Project Breast Cancer Chemoprevention Trials. Vogel VG; Costantino JP; Wickerham DL; McCaskill-Stevens W; Clarfeld RB; Grant MD; Wolmark N J Natl Cancer Inst Monogr; 2010; 2010(41):181-6. PubMed ID: 20956826 [TBL] [Abstract][Full Text] [Related]
13. Current concepts in breast cancer chemoprevention. Chlebowski RT Pol Arch Med Wewn; 2014; 124(4):191-9. PubMed ID: 24618912 [TBL] [Abstract][Full Text] [Related]
14. SERMs for the treatment and prevention of breast cancer. Swaby RF; Sharma CG; Jordan VC Rev Endocr Metab Disord; 2007 Sep; 8(3):229-39. PubMed ID: 17440819 [TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Park WC; Jordan VC Trends Mol Med; 2002 Feb; 8(2):82-8. PubMed ID: 11815274 [TBL] [Abstract][Full Text] [Related]
16. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer. Dhingra K Cancer Invest; 2001; 19(6):649-59. PubMed ID: 11486708 [TBL] [Abstract][Full Text] [Related]
17. Breast cancer chemoprevention. Rosenbaum Smith SM; Osborne MP Am J Surg; 2000 Oct; 180(4):249-51. PubMed ID: 11113429 [TBL] [Abstract][Full Text] [Related]
18. Chemoprevention for high-risk women: tamoxifen and beyond. Fabian CJ; Kimler BF Breast J; 2001; 7(5):311-20. PubMed ID: 11906441 [TBL] [Abstract][Full Text] [Related]
19. Breast cancer prevention trials using retinoids. Decensi A; Serrano D; Bonanni B; Cazzaniga M; Guerrieri-Gonzaga A J Mammary Gland Biol Neoplasia; 2003 Jan; 8(1):19-30. PubMed ID: 14587861 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen to raloxifene and beyond. O'Regan RM; Jordan VC Semin Oncol; 2001 Jun; 28(3):260-73. PubMed ID: 11402436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]